NeuroBo Pharmaceuticals (NRBO) Stock Chart & Stock Price History → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free NRBO Stock Alerts $4.60 +0.36 (+8.49%) (As of 05/16/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media NeuroBo Pharmaceuticals Stock Price Performance5 Day Performance+16.16%1 Month Performance+32.95%3 Month Performance-12.71%6 Month Performance+31.22%Year-To-Date Performance+24.44%1 Year Performance0.00% Receive NRBO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NeuroBo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 Media“Dollar Will Be Worth NOTHING” -MuskElon Musk just issued an urgent warning… Saying “The U.S. Dollar will be worth NOTHING…” As "stealth money printing" pushes the price of Bitcoin, Ethereum, XRP and crypto higher.Click here to claim your free seat ticket now. NRBO Stock Chart for Friday, May, 17, 2024 NRBO Chart by TradingView NeuroBo Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/16/2024$4.24$4.60+8.49%$4.63$4.1255,863 shs$22.59 million05/15/2024$4.11$4.24+3.16%$4.24$4.0813,501 shs$20.82 million05/14/2024$3.96$4.11+3.79%$4.11$3.9612,907 shs$20.18 million05/13/2024$3.96$3.96$4.10$3.955,566 shs$19.44 million05/10/2024$4.00$3.96-0.88%$4.00$3.9015,915 shs$19.43 million05/09/2024$3.93$4.00+1.65%$4.06$3.8535,344 shs$19.62 million Get the Latest News and Ratings for NRBO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NeuroBo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/08/2024$3.84$3.93+2.34%$4.00$3.8419,408 shs$19.30 million05/07/2024$3.80$3.84+1.05%$4.03$3.7037,723 shs$18.85 million05/06/2024$3.78$3.80+0.53%$3.93$3.7012,823 shs$18.66 million05/03/2024$3.73$3.78+1.34%$3.80$3.6022,109 shs$18.56 million05/02/2024$3.68$3.73+1.36%$3.73$3.5514,904 shs$18.31 million05/01/2024$3.30$3.68+11.52%$3.68$3.3560,029 shs$18.07 million04/30/2024$3.23$3.30+2.17%$3.40$3.2542,189 shs$16.20 million04/29/2024$3.14$3.23+2.87%$3.23$3.1012,214 shs$15.86 million04/26/2024$3.06$3.10+1.31%$3.10$3.0117,307 shs$15.22 million04/25/2024$3.10$3.06-1.29%$3.16$3.031,823 shs$15.01 million04/24/2024$3.02$3.10+2.65%$3.50$2.9939,253 shs$15.22 million04/23/2024$3.12$3.02-3.21%$3.19$2.9942,194 shs$14.83 million04/22/2024$3.37$3.12-7.42%$3.27$3.0823,389 shs$15.32 million04/19/2024$3.40$3.37-0.88%$3.49$3.2620,537 shs$16.55 million04/18/2024$3.46$3.40-1.73%$3.63$3.3522,788 shs$16.69 million04/17/2024$3.40$3.46+1.76%$3.69$3.4611,485 shs$16.99 million04/16/2024$3.53$3.40-3.68%$3.62$3.3312,910 shs$16.69 million04/15/2024$3.61$3.53-2.22%$3.73$3.4922,867 shs$17.33 million04/12/2024$3.58$3.61+0.84%$3.95$3.5875,302 shs$17.73 million04/11/2024$3.56$3.58+0.56%$3.69$3.5614,698 shs$17.56 million04/10/2024$3.53$3.56+0.85%$3.66$3.5013,047 shs$17.48 million04/09/2024$3.97$3.53-11.08%$3.93$3.4747,503 shs$17.33 million04/08/2024$3.88$3.97+2.32%$3.97$3.7713,359 shs$19.49 million04/05/2024$3.89$3.88-0.26%$3.94$3.7524,656 shs$19.05 million04/04/2024$3.89$3.89$4.04$3.8224,739 shs$19.10 million04/03/2024$3.93$3.89-1.02%$4.07$3.8013,935 shs$19.10 million04/02/2024$4.06$3.93-3.20%$4.12$3.8527,715 shs$19.06 million04/01/2024$4.09$4.06-0.73%$4.16$3.8049,882 shs$19.70 million03/29/2024$4.09$4.09$4.39$4.0735,570 shs$19.84 million03/28/2024$4.34$4.09-5.76%$4.39$4.0734,044 shs$19.84 million03/27/2024$4.30$4.34+0.93%$4.57$4.1721,612 shs$21.05 million03/26/2024$4.39$4.30-1.94%$4.38$4.2273,948 shs$20.86 million03/25/2024$4.46$4.39-1.68%$4.60$4.3450,797 shs$21.27 million03/22/2024$4.58$4.46-2.62%$4.73$4.4022,616 shs$21.63 millionObama’s Forever Term [exposed] (Ad)America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision.Start streaming it now at no cost here03/21/2024$4.39$4.58+4.33%$4.67$4.3967,872 shs$22.21 million03/20/2024$4.11$4.39+6.81%$4.44$4.1440,291 shs$21.29 million03/19/2024$4.34$4.11-5.30%$4.40$4.1168,991 shs$19.93 million03/18/2024$4.60$4.34-5.65%$4.65$4.3236,590 shs$21.05 million03/15/2024$4.55$4.60+1.10%$4.72$4.5431,075 shs$22.31 million03/14/2024$4.47$4.55+1.79%$4.71$4.3848,003 shs$22.07 million03/13/2024$4.87$4.47-8.21%$5.05$4.34314,434 shs$21.68 million03/12/2024$5.12$4.87-4.88%$5.28$4.7652,195 shs$23.63 million03/11/2024$5.36$5.12-4.48%$5.53$5.1143,095 shs$24.83 million03/08/2024$5.46$5.36-1.83%$5.65$5.3630,464 shs$26.00 million03/07/2024$5.61$5.46-2.67%$5.71$5.35113,303 shs$27.22 million03/06/2024$6.29$5.61-10.81%$6.29$5.55140,365 shs$27.21 million03/05/2024$6.52$6.29-3.53%$6.68$6.1483,520 shs$30.51 million03/04/2024$6.24$6.52+4.49%$6.75$6.06261,398 shs$31.62 million03/01/2024$5.79$6.24+7.77%$6.34$5.52407,225 shs$30.26 million02/29/2024$5.12$5.79+13.09%$5.97$5.153.33 million shs$28.08 million02/28/2024$4.81$5.12+6.44%$5.30$4.8560,237 shs$24.83 million02/27/2024$5.59$4.81-13.95%$5.66$4.76103,778 shs$23.34 million02/26/2024$5.30$5.59+5.47%$5.61$5.3582,136 shs$27.11 million02/23/2024$5.73$5.30-7.57%$5.85$5.2063,371 shs$25.71 million02/22/2024$5.82$5.73-1.48%$5.86$5.5083,758 shs$27.82 million02/21/2024$5.35$5.82+8.79%$5.84$5.27123,318 shs$28.23 million02/20/2024$5.27$5.35+1.52%$5.39$4.9260,378 shs$25.95 million02/19/2024$5.27$5.27$5.30$4.74118,900 shs$25.56 million02/16/2024$4.83$5.27+9.11%$5.30$4.74118,662 shs$25.56 million Related Companies: KALA BIO Stock Price Chart BioVie Stock Price Chart Synlogic Stock Price Chart Cocrystal Pharma Stock Price Chart Alaunos Therapeutics Stock Price Chart Lumos Pharma Stock Price Chart Orgenesis Stock Price Chart Indaptus Therapeutics Stock Price Chart Sol-Gel Technologies Stock Price Chart MEI Pharma Stock Price Chart Receive NRBO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NeuroBo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NRBO) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDoes this make you sick?Allegiance GoldWhy Is Gold On a MASSIVE rally? Huge AlertsUrgent Alert: Is the U.S. Implementing a Digital Dollar?Gold Gate Capital348 million Americans lives to END as we know it?The Oxford ClubBiden Nomination CANCELED?The Freeport SocietyGold Set to EXPLODE!Gold Safe ExchangeDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroBo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.